4'-((2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl)-2'-(chloromethyl)-N-(4,5-dimethylisoxazol-3-yl)-[1,1'-biphenyl]-2-sulfonamide
RE-0004091 (PS359607) is a fully characterized chemical compound used as a reference standard of API Sparsentan. The standard offered is compliant with regulatory guidelines. RE-0004091 (PS359607) is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - N/A
